Revisão Acesso aberto Revisado por pares

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

2022; Nature Portfolio; Volume: 18; Issue: 11 Linguagem: Inglês

10.1038/s41581-022-00618-4

ISSN

1759-507X

Autores

Duvuru Geetha, Andreas Kronbichler, Megan Rutter, Divya Bajpai, Steven Menez, Annemarie Weißenbacher, Shuchi Anand, Eugene Lin, Nicholas Carlson, Stephen M. Sozio, Kevin Fowler, Ray Bignall, Kathryn Ducharlet, Elliot Koranteng Tannor, Eranga Wijewickrama, Muhammad I. A. Hafidz, Vladimı́r Tesař, Robert S. Hoover, Deidra C. Crews, Charles D. Varnell, Lara Danziger‐Isakov, Vivekanand Jha, Sumit Mohan, Chirag R. Parikh, Valérie A. Luyckx,

Tópico(s)

Muscle and Compartmental Disorders

Resumo

The coronavirus disease 2019 (COVID-19) pandemic has disproportionately affected patients with kidney disease, causing significant challenges in disease management, kidney research and trainee education. For patients, increased infection risk and disease severity, often complicated by acute kidney injury, have contributed to high mortality. Clinicians were faced with high clinical demands, resource shortages and novel ethical dilemmas in providing patient care. In this review, we address the impact of COVID-19 on the entire spectrum of kidney care, including acute kidney injury, chronic kidney disease, dialysis and transplantation, trainee education, disparities in health care, changes in health care policies, moral distress and the patient perspective. Based on current evidence, we provide a framework for the management and support of patients with kidney disease, infection mitigation strategies, resource allocation and support systems for the nephrology workforce. In this Review, the authors summarize the challenges associated with the care of patients with kidney disease during the COVID-19 pandemic. They describe the major challenges and missed opportunities, global inequalities in health care, and offer a framework for future pandemic preparedness.

Referência(s)